STERIS’ (TSE:STE – Free Report) – Research analysts at Cormark dropped their FY2026 earnings per share (EPS) estimates for shares of STERIS’ in a research note issued to investors on Friday, May 16th. Cormark analyst B. Watson now expects that the company will post earnings of $0.51 per share for the year, down from their prior forecast of $0.61.
Separately, Raymond James lowered STERIS’ from a “moderate buy” rating to a “hold” rating in a report on Wednesday, April 9th.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Manufacturing Stocks Investing
- What Ray Dalio’s Latest Moves Tell Investors
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
